nafamostat has been researched along with Brain Hemorrhage in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafamostat mesilate (NM) is a synthetic protease-inhibiting agent that has not only potent inhibitory activity against coagulation factors (Xlla, Xa) but also an anti-inflammatory action." | 5.40 | Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke. ( Gotake, Y; Inoue, T; Izawa, N; Kano, H; Matsumori, M; Miyahara, S; Okada, K; Okita, Y; Sakamoto, T, 2014) |
| "Nafamostat mesilate (NM) is a synthetic protease-inhibiting agent that has not only potent inhibitory activity against coagulation factors (Xlla, Xa) but also an anti-inflammatory action." | 1.40 | Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke. ( Gotake, Y; Inoue, T; Izawa, N; Kano, H; Matsumori, M; Miyahara, S; Okada, K; Okita, Y; Sakamoto, T, 2014) |
| "Generally, patients with a recent intracranial hemorrhage are believed to be a contraindication to undergo cardiac surgery with cardiopulmonary bypass." | 1.34 | Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage. ( Kano, H; Okada, K; Okita, Y; Ota, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamoto, T | 1 |
| Kano, H | 2 |
| Miyahara, S | 1 |
| Inoue, T | 1 |
| Izawa, N | 1 |
| Gotake, Y | 1 |
| Matsumori, M | 1 |
| Okada, K | 2 |
| Okita, Y | 2 |
| Morimoto, N | 1 |
| Henmi, S | 1 |
| Yoshida, M | 1 |
| Mukohara, N | 1 |
| Ota, T | 1 |
3 other studies available for nafamostat and Brain Hemorrhage
| Article | Year |
|---|---|
Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke.
Topics: Adult; Aged; Anticoagulants; Benzamidines; Blood Coagulation Tests; Cardiac Surgical Procedures; Car | 2014 |
Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzamidines; Cardiac Surgical Procedures; Cardiopulmonary | 2012 |
Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage.
Topics: Adult; Aged; Benzamidines; Cardiopulmonary Bypass; Endocarditis, Bacterial; Female; Guanidines; Huma | 2007 |